USMLE Step 1 Electrolyte Disorders

Mastering electrolyte disorders is non-negotiable for USMLE Step 1 success, as these questions integrate core principles of renal physiology, acid-base balance, pharmacology, and clinical reasoning. A firm grasp not only helps you answer discrete questions but also provides the foundational knowledge required for complex multi-system vignettes. This guide will move you from recognizing patterns to confidently executing treatment plans under exam pressure.

Understanding Sodium: Volume Status is Everything

Sodium disorders are almost always disorders of water balance, not total body sodium. Your first and most critical step is assessing the patient’s volume status—hypovolemic, euvolemic, or hypervolemic—as this dictates the differential diagnosis and treatment.

Hyponatremia (serum Na+ < 135 mEq/L) presents with neurological symptoms like headache, confusion, seizures, and coma due to cerebral edema. The diagnostic framework hinges on measured serum osmolality and volume status. Most cases are hypotonic. For Step 1, the key etiologies are:

• Hypovolemic: Total body water (TBW) ↓↓, total body Na+ ↓. Think diuretic overuse, vomiting, diarrhea, or third-spacing. The body responds with ADH (vasopressin) release to preserve volume, causing water retention and dilutional hyponatremia.
• Euvolemic: TBW ↑, total body Na+ normal. The classic cause is SIADH (Syndrome of Inappropriate ADH Secretion), seen with CNS disease, pulmonary pathology, or certain drugs. Adrenal insufficiency and hypothyroidism are also on the list.
• Hypervolemic: TBW ↑↑, total body Na+ ↑↑ (but TBW increases more). Seen in heart failure, cirrhosis, and nephrotic syndrome. Effective arterial blood volume is low, triggering ADH and RAAS activation.

Hypernatremia (serum Na+ > 145 mEq/L) always signifies a water deficit. Symptoms include thirst, lethargy, muscle twitching, and coma from cellular dehydration. Etiologies are either water loss (diabetes insipidus—central vs. nephrogenic—or osmotic diuresis) or, less commonly, sodium gain (hypertonic saline infusion, hyperaldosteronism).

Calculating osmolality is a frequent Step 1 task. You must know the formula for estimated serum osmolality: $$\text{Serum Osmolality (mOsm/kg)}=2[{\text{Na}}^{+}]+\frac{[\text{Glucose}]}{18}+\frac{[\text{BUN}]}{2.8}$$ A large difference between measured and calculated osmolality (>10) indicates an osmolar gap, typically due to the presence of unmeasured osmoles like ethanol, methanol, or ethylene glycol.

Potassium: The Cardiac Electrophysiology Connection

Potassium is critical for resting membrane potential. Disorders profoundly affect excitable tissues, especially the heart, making EKG pattern recognition essential.

Hypokalemia (K+ < 3.5 mEq/L) causes muscle weakness, ileus, and U waves on EKG. Causes include:

• Transcellular shifts: Alkalosis, insulin administration, beta-2 agonists.
• Renal losses: The most common exam pathway. This includes hyperaldosteronism (primary or secondary), diuretics (thiazides and loop diuretics), and renal tubular acidosis (RTA), especially Type 1 and 2.
• GI losses: Vomiting, diarrhea, laxative abuse.

Hyperkalemia (K+ > 5.0 mEq/L) is life-threatening. Symptoms range from weakness to fatal arrhythmias. EKG changes progress predictably: Peaked T waves → Loss of P waves → Widening QRS → Sine wave pattern → VF arrest. Memorize the "MACHINE" mnemonic for causes: Medications (ACEi, ARBs, K+-sparing diuretics, NSAIDs), Acidosis, Cellular damage (rhabdomyolysis, tumor lysis), Hypoaldosteronism (Addison's, Type 4 RTA), Inake (excessive), Nephrons (renal failure), Excretion impaired.

Treatment strategies are a major USMLE focus. For hyperkalemia with EKG changes, the sequence is:

1. Stabilize the myocardium with calcium gluconate (does not lower serum K+).
2. Shift potassium intracellularly with insulin + glucose, beta-2 agonists (albuterol), and sodium bicarbonate (if acidotic).
3. Remove potassium from the body with loop diuretics, kayexalate, or dialysis.

Calcium and Phosphate: The Inverse Relationship

Calcium and phosphate are inversely regulated by PTH and vitamin D. Understanding this axis is key.

Hypercalcemia (Corrected Ca > 10.5 mg/dL) classically presents with "stones, bones, groans, and psychiatric overtones" (nephrolithiasis, bone pain, abdominal pain/constipation, confusion/depression). The EKG may show a shortened QT interval. The top two causes for Step 1 are hyperparathyroidism (primary) and malignancy (via PTHrP or bone metastases). Initial treatment involves vigorous IV normal saline (volume expansion) followed by bisphosphonates (e.g., pamidronate) to inhibit bone resorption.

Hypocalcemia (Corrected Ca < 8.5 mg/dL) causes neuromuscular excitability: perioral/finger numbness, Chvostek's sign (facial muscle twitch), Trousseau's sign (carpopedal spasm with blood pressure cuff inflation), and seizures. The EKG shows a prolonged QT interval. Common etiologies include post-thyroidectomy (parathyroid damage), chronic kidney disease (low vitamin D activation, hyperphosphatemia), and vitamin D deficiency. Acute treatment is with IV calcium gluconate.

Phosphate disorders are less common but testable. Hypophosphatemia can cause muscle weakness (including diaphragmatic → respiratory failure) and confusion. Think refeeding syndrome in a malnourished patient or DKA treatment (phosphate shifts intracellularly with insulin). Hyperphosphatemia is most often seen in renal failure due to decreased excretion and is managed with phosphate binders like calcium acetate or sevelamer.

Step 1 Strategy: Integrating Systems and Pharmacology

Electrolyte questions are rarely just recall. They test integrated thinking. Follow this approach:

1. Identify the Abnormality: Look at the lab values first.
2. Associate the Clinical Clue: Match symptoms (e.g., muscle weakness, EKG changes, neurological signs) and context (post-op, medication list, comorbid conditions like CHF or CKD).
3. Apply the Physiology: Use volume status for sodium, the PTH/vitamin D axis for calcium/phosphate, and renal/acid-base principles for potassium.
4. Recall the Pharmacologic Intervention: Know the first-line, immediate, and chronic treatments for each condition. For example, knowing that vasopressin (ADH) receptor antagonists (vaptans like tolvaptan) are used for euvolemic/hypervolemic hyponatremia, or that fomepizole is the antidote for toxic alcohol ingestion causing an osmolar gap.

Common Pitfalls

• Mistaking SIADH for Psychogenic Polydipsia: Both cause euvolemic hyponatremia. The key differentiator is urine osmolality. In SIADH, the urine is inappropriately concentrated (>100 mOsm/kg, often >300). In primary polydipsia, the urine is appropriately dilute (<100 mOsm/kg).
• Treating Hyperkalemia Out of Sequence: Administering insulin/glucose without checking for EKG changes and considering calcium for myocardial stabilization is a dangerous error. Calcium is the first-line therapy for cardiac instability.
• Forgetting to Correct Calcium for Albumin: Always check if an albumin level is provided. The corrected calcium formula is: $$\text{Corrected Ca}=\text{Measured Ca}+0.8\times (4.0-\text{[Albumin]})$$. A low albumin can mask true hypercalcemia or exaggerate hypocalcemia.
• Confusing Central and Nephrogenic DI: Both cause hypernatremia and polyuria. The test is the water deprivation test followed by desmopressin (ADH) administration. In central DI, the kidney works fine, so desmopressin will concentrate the urine. In nephrogenic DI, the kidney is resistant, so desmopressin does nothing.

Summary

• Sodium disorders are disorders of water balance; always start your differential by clinically assessing volume status (hypo-, eu-, or hypervolemic).
• Potassium imbalances are urgent and manifest on EKG: Hypokalemia causes U waves and is often from renal losses; Hyperkalemia causes peaked T waves and can be fatal—remember the treatment sequence: Calcium → Insulin/Glucose → Removal.
• Calcium and phosphate are inversely regulated by PTH/vitamin D. Hypercalcemia (short QT) is most often from hyperparathyroidism or malignancy, treated with fluids/bisphosphonates. Hypocalcemia (long QT, tetany) is classic post-thyroidectomy.
• For Step 1, integrate clinical presentation, lab values, and underlying physiology to identify the root cause. Your knowledge of specific drug mechanisms (diuretics, bisphosphonates, vaptans, kayexalate) is frequently the final step to selecting the correct answer.